{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T05:49:29Z","timestamp":1794894569769,"version":"4.9.1"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,10,27]],"date-time":"2009-10-27T00:00:00Z","timestamp":1256601600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1208\/s12248-009-9146-8","type":"journal-article","created":{"date-parts":[[2009,10,26]],"date-time":"2009-10-26T16:16:10Z","timestamp":1256573770000},"source":"Crossref","is-referenced-by-count":235,"title":["Herb\u2013Drug Interactions with St John\u2019s Wort (Hypericum perforatum): an Update on Clinical Observations"],"prefix":"10.1208","volume":"11","author":[{"given":"Francesca","family":"Borrelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo A.","family":"Izzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,10,27]]},"reference":[{"key":"9146_CR1","first-page":"64","volume":"71","author":"M Blumenthal","year":"2006","unstructured":"Blumenthal M, Ferrier GKL, Cavaliere C. Total sales of herbal supplements in United States show steady growth. Herbal Gram. 2006;71:64\u20136.","journal-title":"Herbal Gram"},{"key":"9146_CR2","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s11606-008-0632-y","volume":"23","author":"S Bent","year":"2008","unstructured":"Bent S. Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center. J Gen Intern Med. 2008;23:854\u20139.","journal-title":"J Gen Intern Med"},{"key":"9146_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1472-8206.2004.00301.x","volume":"19","author":"AA Izzo","year":"2005","unstructured":"Izzo AA. Herb\u2013drug interactions: an overview of the clinical evidence. Fundam Clin Pharmacol. 2005;19:1\u201316.","journal-title":"Fundam Clin Pharmacol"},{"key":"9146_CR4","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1365-2125.2006.02797.x","volume":"63","author":"PA Smet De","year":"2007","unstructured":"De Smet PA. Clinical risk management of herb\u2013drug interactions. Br J Clin Pharmacol. 2007;63:258\u201367.","journal-title":"Br J Clin Pharmacol"},{"key":"9146_CR5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5414\/CPP42139","volume":"42","author":"AA Izzo","year":"2004","unstructured":"Izzo AA. Drug interactions with St. John\u2019s Wort (Hypericum perforatum): a review of the clinical evidence. Int J Clin Pharmacol Ther. 2004;42:139\u201348.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"9146_CR6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.2174\/138920008784746391","volume":"9","author":"SF Zhou","year":"2008","unstructured":"Zhou SF, Lai X. An update on clinical drug interactions with the herbal antidepressant St. John\u2019s wort. Curr Drug Metab. 2008;9:394\u2013409.","journal-title":"Curr Drug Metab"},{"key":"9146_CR7","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.2174\/138920008786927767","volume":"9","author":"M Kober","year":"2008","unstructured":"Kober M, Pohl K, Efferth T. Molecular mechanisms underlying St. John\u2019s wort drug interactions. Curr Drug Metab. 2008;9:1027\u201337.","journal-title":"Curr Drug Metab"},{"key":"9146_CR8","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.2174\/138161208784746798","volume":"14","author":"YM Di","year":"2008","unstructured":"Di YM, Li CG, Xue CC, Zhou SF. Clinical drugs that interact with St. John\u2019s wort and implication in drug development. Curr Pharm Des. 2008;14:1723\u201342.","journal-title":"Curr Pharm Des"},{"key":"9146_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1192\/bjp.186.2.99","volume":"186","author":"K Linde","year":"2005","unstructured":"Linde K, Berner M, Egger M, Mulrow C. St John\u2019s wort for depression: meta-analysis of randomised controlled trials. Br J Psychiatry. 2005;186:99\u2013107.","journal-title":"Br J Psychiatry"},{"key":"9146_CR10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00004650-200607000-00008","volume":"20","author":"K Clement","year":"2006","unstructured":"Clement K, Covertson CR, Johnson MJ, Dearing K. St. John\u2019s wort and the treatment of mild to moderate depression: a systematic review. Holist Nurs Pract. 2006;20:197\u2013203.","journal-title":"Holist Nurs Pract"},{"key":"9146_CR11","doi-asserted-by":"crossref","unstructured":"Linde K, Berner MM, Kriston L. St John\u2019s wort for major depression. Cochrane Database Syst Rev. 2008;CD000448.","DOI":"10.1002\/14651858.CD000448.pub3"},{"key":"9146_CR12","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S0165-6147(00)01716-8","volume":"22","author":"G Carlo Di","year":"2001","unstructured":"Di Carlo G, Borrelli F, Ernst E, Izzo AA. St John\u2019s wort: prozac from the plant kingdom. Trends Pharmacol Sci. 2001;22:292\u20137.","journal-title":"Trends Pharmacol Sci"},{"key":"9146_CR13","volume-title":"Phytotherapy. A quick reference to herbal medicine","author":"F Capasso","year":"2003","unstructured":"Capasso F, Gaginella TS, Grandolini G, Izzo AA. Phytotherapy. A quick reference to herbal medicine. Berlin: Springer; 2003."},{"key":"9146_CR14","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/j.1365-2125.2006.02755.x","volume":"62","author":"DL Whitten","year":"2006","unstructured":"Whitten DL, Myers SP, Hawrelak JA, Wohlmuth H. The effect of St John\u2019s wort extracts on CYP3A: a systematic review of prospective clinical trials. Br J Clin Pharmacol. 2006;62:512\u201326.","journal-title":"Br J Clin Pharmacol"},{"key":"9146_CR15","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.cvsm.2006.05.003","volume":"36","author":"LA Trepanier","year":"2006","unstructured":"Trepanier LA. Cytochrome P450 and its role in veterinary drug interactions. Vet Clin North Am Small Anim Pract. 2006;36:975\u201385.","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"9146_CR16","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/mnfr.200600300","volume":"52","author":"BJ Gurley","year":"2008","unstructured":"Gurley BJ, Swain A, Hubbard MA, Williams DK, Barone G, Hartsfield F, et al. Clinical assessment of CYP2D6-mediated herb\u2013drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John\u2019s wort, and Echinacea. Mol Nutr Food Res. 2008;52:755\u201363.","journal-title":"Mol Nutr Food Res"},{"key":"9146_CR17","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2165\/00002512-200522060-00006","volume":"22","author":"BJ Gurley","year":"2005","unstructured":"Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y, et al. Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John\u2019s wort, garlic oil, Panax ginseng and Ginkgo biloba. Drugs Aging. 2005;22:525\u201339.","journal-title":"Drugs Aging"},{"key":"9146_CR18","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1067\/mcp.2002.126913","volume":"72","author":"BJ Gurley","year":"2002","unstructured":"Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y, et al. Cytochrome P450 phenotypic ratios for predicting herb\u2013drug interactions in humans. Clin Pharmacol Ther. 2002;72:276\u201387.","journal-title":"Clin Pharmacol Ther"},{"key":"9146_CR19","doi-asserted-by":"publisher","first-page":"PL133","DOI":"10.1016\/S0024-3205(99)00659-1","volume":"66","author":"JS Markowitz","year":"2000","unstructured":"Markowitz JS, DeVane CL, Boulton DW, Carson SW, Nahas Z, Risch SC. Effect of St. John\u2019s wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers. Life Sci. 2000;66:PL133\u20139.","journal-title":"Life Sci"},{"key":"9146_CR20","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1001\/jama.290.11.1500","volume":"290","author":"JS Markowitz","year":"2003","unstructured":"Markowitz JS, Donovan JL, DeVane CL, Taylor RM, Ruan Y, Wang JS, et al. Effect of St John\u2019s wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA. 2003;290:1500\u20134.","journal-title":"JAMA"},{"key":"9146_CR21","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1055\/s-2005-864099","volume":"71","author":"G Arold","year":"2005","unstructured":"Arold G, Donath F, Maurer A, Diefenbach K, Bauer S, Henneicke-von Zepelin HH, et al. No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John\u2019s wort extract. Planta Med. 2005;71:331\u20137.","journal-title":"Planta Med"},{"key":"9146_CR22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0009-9236(01)00127-8","volume":"70","author":"Z Wang","year":"2001","unstructured":"Wang Z, Gorski JC, Hamman MA, Huang SM, Lesko LJ, Hall SD. The effects of St John\u2019s wort (Hypericum perforatum) on human cytochrome P450 activity. Clin Pharmacol Ther. 2001;70:317\u201326.","journal-title":"Clin Pharmacol Ther"},{"key":"9146_CR23","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1177\/0091270004265642","volume":"44","author":"LS Wang","year":"2004","unstructured":"Wang LS, Zhu B, Abd El-Aty AM, Zhou G, Li Z, Wu J, et al. The influence of St John\u2019s Wort on CYP2C19 activity with respect to genotype. J Clin Pharmacol. 2004;44:577\u201381.","journal-title":"J Clin Pharmacol"},{"key":"9146_CR24","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/j.1365-2125.2003.02049.x","volume":"57","author":"M Wenk","year":"2004","unstructured":"Wenk M, Todesco L, Kr\u00e4henb\u00fchl S. Effect of St John\u2019s wort on the activities of CYP1A2, CYP3A4, CYP2D6, N-acetyltransferase 2, and xanthine oxidase in healthy males and females. Br J Clin Pharmacol. 2004;57:495\u20139.","journal-title":"Br J Clin Pharmacol"},{"key":"9146_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1067\/mcp.2003.10","volume":"73","author":"GK Dresser","year":"2003","unstructured":"Dresser GK, Schwarz UI, Wilkinson GR, Kim RB. Coordinate induction of both cytochrome P4503A and MDR1 by St John\u2019s wort in healthy subjects. Clin Pharmacol Ther. 2003;73:41\u201350.","journal-title":"Clin Pharmacol Ther"},{"key":"9146_CR26","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/00004714-200110000-00013","volume":"21","author":"CA Roby","year":"2001","unstructured":"Roby CA, Dryer DA, Burstein AH. St. John\u2019s wort: effect on CYP2D6 activity using dextromethorphan\u2013dextrorphan ratios. J Clin Psychopharmacol. 2001;21:530\u20132.","journal-title":"J Clin Psychopharmacol"},{"key":"9146_CR27","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1177\/0091270004273320","volume":"45","author":"R Xie","year":"2005","unstructured":"Xie R, Tan LH, Polasek EC, Hong C, Teillol-Foo M, Gordi T, et al. CYP3A and P-glycoprotein activity induction with St. John\u2019s Wort in healthy volunteers from 6 ethnic populations. J Clin Pharmacol. 2005;45:352\u20136.","journal-title":"J Clin Pharmacol"},{"key":"9146_CR28","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.clpt.2003.08.009","volume":"74","author":"SD Hall","year":"2003","unstructured":"Hall SD, Wang Z, Huang SM, Hamman MA, Vasavada N, Adigun AQ, et al. The interaction between St John\u2019s wort and an oral contraceptive. Clin Pharmacol Ther. 2003;74:525\u201335.","journal-title":"Clin Pharmacol Ther"},{"key":"9146_CR29","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/j.1365-2125.2008.03120.x","volume":"65","author":"H Imai","year":"2008","unstructured":"Imai H, Kotegawa T, Tsutsumi K, Morimoto T, Eshima N, Nakano S, et al. The recovery time-course of CYP3A after induction by St John\u2019s wort administration. Br J Clin Pharmacol. 2008;65:701\u20137.","journal-title":"Br J Clin Pharmacol"},{"key":"9146_CR30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.clpt.2003.09.014","volume":"75","author":"LS Wang","year":"2004","unstructured":"Wang LS, Zhou G, Zhu B, Wu J, Wang JG, Abd El-Aty AM, et al. St John\u2019s wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole. Clin Pharmacol Ther. 2004;75:191\u20137.","journal-title":"Clin Pharmacol Ther"},{"key":"9146_CR31","doi-asserted-by":"publisher","first-page":"7500","DOI":"10.1073\/pnas.130155097","volume":"97","author":"LB Moore","year":"2000","unstructured":"Moore LB, Goodwin B, Jones SA, Wisely GB, Serabjit-Singh CJ, Willson TM, et al. St. John\u2019s wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA. 2000;97:7500\u20132.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9146_CR32","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1080\/00498250701867889","volume":"38","author":"SF Zhou","year":"2008","unstructured":"Zhou SF. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica. 2008;38:802\u201332.","journal-title":"Xenobiotica"},{"key":"9146_CR33","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1038\/sj.bjp.0704399","volume":"134","author":"MD Perloff","year":"2001","unstructured":"Perloff MD, von Moltke LL, St\u00f6rmer E, Shader RI, Greenblatt DJ. Saint John\u2019s wort: an in vitro analysis of P-glycoprotein induction due to extended exposure. Br J Pharmacol. 2001;134:1601\u20138.","journal-title":"Br J Pharmacol"},{"key":"9146_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1046\/j.0306-5251.2001.01516.x","volume":"53","author":"M Hennessy","year":"2002","unstructured":"Hennessy M, Kelleher D, Spiers JP, Barry M, Kavanagh P, Back D, et al. St Johns wort increases expression of P-glycoprotein: implications for drug interactions. Br J Clin Pharmacol. 2002;53:75\u201382.","journal-title":"Br J Clin Pharmacol"},{"key":"9146_CR35","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1053\/cp.1999.v66.a101944","volume":"66","author":"A Johne","year":"1999","unstructured":"Johne A, Brockm\u00f6ller J, Bauer S, Maurer A, Langheinrich M, Roots I. Pharmacokinetic interaction of digoxin with an herbal extract from St John\u2019s wort (Hypericum perforatum). Clin Pharmacol Ther. 1999;66:338\u201345.","journal-title":"Clin Pharmacol Ther"},{"key":"9146_CR36","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.clpt.2004.01.014","volume":"75","author":"SC Mueller","year":"2004","unstructured":"Mueller SC, Uehleke B, Woehling H, Petzsch M, Majcher-Peszynska J, Hehl EM, et al. Effect of St John\u2019s wort dose and preparations on the pharmacokinetics of digoxin. Clin Pharmacol Ther. 2004;75:546\u201357.","journal-title":"Clin Pharmacol Ther"},{"key":"9146_CR37","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1067\/mcp.2000.112240","volume":"68","author":"D D\u00fcrr","year":"2000","unstructured":"D\u00fcrr D, Stieger B, Kullak-Ublick GA, Rentsch KM, Steinert HC, Meier PJ, et al. St John\u2019s Wort induces intestinal P-glycoprotein\/MDR1 and intestinal and hepatic CYP3A4. Clin Pharmacol Ther. 2000;68:598\u2013604.","journal-title":"Clin Pharmacol Ther"},{"key":"9146_CR38","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/sj.clpt.6100191","volume":"81","author":"UI Schwarz","year":"2007","unstructured":"Schwarz UI, Hanso H, Oertel R, Miehlke S, Kuhlisch E, Glaeser H, et al. Induction of intestinal P-glycoprotein by St John\u2019s wort reduces the oral bioavailability of talinolol. Clin Pharmacol Ther. 2007;81:669\u201378.","journal-title":"Clin Pharmacol Ther"},{"key":"9146_CR39","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1067\/mcp.2002.124080","volume":"71","author":"Z Wang","year":"2002","unstructured":"Wang Z, Hamman MA, Huang SM, Lesko LJ, Hall SD. Effect of St John\u2019s wort on the pharmacokinetics of fexofenadine. Clin Pharmacol Ther. 2002;71:414\u201320.","journal-title":"Clin Pharmacol Ther"},{"key":"9146_CR40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.clpt.2005.01.024","volume":"78","author":"J Rengelshausen","year":"2005","unstructured":"Rengelshausen J, Banfield M, Riedel KD, Burhenne J, Weiss J, Thomsen T, et al. Opposite effects of short-term and long-term St John\u2019s wort intake on voriconazole pharmacokinetics. Clin Pharmacol Ther. 2005;78:25\u201333.","journal-title":"Clin Pharmacol Ther"},{"key":"9146_CR41","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.clpt.2004.07.004","volume":"76","author":"I Mai","year":"2004","unstructured":"Mai I, Bauer S, Perloff ES, Johne A, Uehleke B, Frank B, et al. Hyperforin content determines the magnitude of the St John\u2019s wort\u2013cyclosporine drug interaction. Clin Pharmacol Ther. 2004;76:330\u201340.","journal-title":"Clin Pharmacol Ther"},{"key":"9146_CR42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00228-005-0061-3","volume":"62","author":"SC Mueller","year":"2006","unstructured":"Mueller SC, Majcher-Peszynska J, Uehleke B, Klammt S, Mundkowski RG, Miekisch W, et al. The extent of induction of CYP3A by St. John\u2019s wort varies among products and is linked to hyperforin dose. Eur J Clin Pharmacol. 2006;62:29\u201336.","journal-title":"Eur J Clin Pharmacol"},{"key":"9146_CR43","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00228-008-0554-y","volume":"65","author":"SC Mueller","year":"2009","unstructured":"Mueller SC, Majcher-Peszynska J, Mundkowski RG, Uehleke B, Klammt S, Sievers H, et al. No clinically relevant CYP3A induction after St. John\u2019s wort with low hyperforin content in healthy volunteers. Eur J Clin Pharmacol. 2009;65:81\u20137.","journal-title":"Eur J Clin Pharmacol"},{"key":"9146_CR44","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/01.qai.0000234089.41785.c8","volume":"43","author":"RF L\u2019homme","year":"2006","unstructured":"L\u2019homme RF, Dijkema T, van der Ven AJ, Burger DM. Brief report: enzyme inducers reduce elimination half-life after a single dose of nevirapine in healthy women. J Acquir Immune Defic Syndr. 2006;43:193\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"9146_CR45","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00228-008-0587-2","volume":"65","author":"L Will-Shahab","year":"2009","unstructured":"Will-Shahab L, Bauer S, Kunter U, Roots I, Brattstr\u00f6m A. St John\u2019s wort extract (Ze 117) does not alter the pharmacokinetics of a low-dose oral contraceptive. Eur J Clin Pharmacol. 2009;65:287\u201394.","journal-title":"Eur J Clin Pharmacol"},{"key":"9146_CR46","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.drudis.2007.06.004","volume":"12","author":"SF Zhou","year":"2007","unstructured":"Zhou SF, Zhou ZW, Li CG, Chen X, Yu X, Xue CC, et al. Identification of drugs that interact with herbs in drug development. Drug Discov Today. 2007;12:664\u201373.","journal-title":"Drug Discov Today"},{"key":"9146_CR47","first-page":"535","volume":"16","author":"S Bon","year":"1999","unstructured":"Bon S, Hartmann K, Kubn M. Johanniskraut: ein enzyminduktor? Schweitzer Apothekerzeitung. 1999;16:535\u20136.","journal-title":"Schweitzer Apothekerzeitung"},{"key":"9146_CR48","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1097\/00007890-200005270-00052","volume":"69","author":"T Breidenbach","year":"2000","unstructured":"Breidenbach T, Kliem V, Burg M, Radermacher J, Hoffmann MW, Klempnauer J. Profound drop of cyclosporin A whole blood trough levels caused by St. John\u2019s wort (Hypericum perforatum). Transplantation. 2000;69:2229\u201330.","journal-title":"Transplantation"},{"key":"9146_CR49","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1016\/S0140-6736(05)73359-6","volume":"355","author":"T Breidenbach","year":"2000","unstructured":"Breidenbach T, Hoffmann MW, Becker T, Schlitt H, Klempnauer J. Drug interaction of St John\u2019s wort with cyclosporin. Lancet. 2000;355:1912.","journal-title":"Lancet"},{"key":"9146_CR50","unstructured":"Roots I, Johne A, Mauer A, et al. Arzneimittel interaktionen von hypericum-extract. Proc Germ Soc Pharmacol. 2000; Berlin."},{"key":"9146_CR51","doi-asserted-by":"crossref","first-page":"583","DOI":"10.5694\/j.1326-5377.1998.tb123424.x","volume":"169","author":"JM Rey","year":"1998","unstructured":"Rey JM, Walter G. Hypericum perforatum (St John\u2019s wort) in depression: pest or blessing? Med J Aust. 1998;169:583\u20136.","journal-title":"Med J Aust"},{"key":"9146_CR52","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/S0140-6736(99)05467-7","volume":"355","author":"F Ruschitzka","year":"2000","unstructured":"Ruschitzka F, Meier PJ, Turina M, L\u00fcscher TF, Noll G. Acute heart transplant rejection due to Saint John\u2019s wort. Lancet. 2000;355:548\u20139.","journal-title":"Lancet"},{"key":"9146_CR53","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1345\/aph.10088","volume":"34","author":"GW Barone","year":"2000","unstructured":"Barone GW, Gurley BJ, Ketel BL, Lightfoot ML, Abul-Ezz SR. Drug interaction between St. John\u2019s wort and cyclosporine. Ann Pharmacother. 2000;34:1013\u20136.","journal-title":"Ann Pharmacother"},{"key":"9146_CR54","doi-asserted-by":"crossref","first-page":"500","DOI":"10.5414\/CPP38500","volume":"38","author":"I Mai","year":"2000","unstructured":"Mai I, Kr\u00fcger H, Budde K, Johne A, Brockm\u00f6ller J, Neumayer HH, et al. Hazardous pharmacokinetic interaction of Saint John\u2019s wort (Hypericum perforatum) with the immunosuppressant cyclosporin. Int J Clin Pharmacol Ther. 2000;38:500\u20132.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"9146_CR55","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0168-8278(00)80321-9","volume":"33","author":"M Karliova","year":"2000","unstructured":"Karliova M, Treichel U, Malag\u00f2 M, Frilling A, Gerken G, Broelsch CE. Interaction of Hypericum perforatum (St. John\u2019s wort) with cyclosporin A metabolism in a patient after liver transplantation. J Hepatol. 2000;33:853\u20135.","journal-title":"J Hepatol"},{"key":"9146_CR56","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/ndt\/15.9.1473","volume":"15","author":"A Mandelbaum","year":"2000","unstructured":"Mandelbaum A, Pertzborn F, Martin-Facklam M, Wiesel M. Unexplained decrease of cyclosporin trough levels in a compliant renal transplant patient. Nephrol Dial Transplant. 2000;15:1473\u20134.","journal-title":"Nephrol Dial Transplant"},{"key":"9146_CR57","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/152692480101100207","volume":"11","author":"SM Turton-Weeks","year":"2001","unstructured":"Turton-Weeks SM, Barone GW, Gurley BJ, Ketel BL, Lightfoot ML, Abul-Ezz SR. St John\u2019s wort: a hidden risk for transplant patients. Prog Transplant. 2001;11:116\u201320.","journal-title":"Prog Transplant"},{"key":"9146_CR58","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1053-2498(00)00221-7","volume":"20","author":"SM Ahmed","year":"2001","unstructured":"Ahmed SM, Banner NR, Dubrey SW. Low cyclosporin-A level due to Saint-John\u2019s-wort in heart transplant patients. J Heart Lung Transplant. 2001;20:795.","journal-title":"J Heart Lung Transplant"},{"key":"9146_CR59","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/PL00002231","volume":"96","author":"AM Beer","year":"2001","unstructured":"Beer AM, Ostermann T. St. John\u2019s wort: interaction with cyclosporine increases risk of rejection for the kidney transplant and raises daily cost of medication. Med Klin (Munich). 2001;96:480\u20133.","journal-title":"Med Klin (Munich)"},{"key":"9146_CR60","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1053\/ajkd.2001.28617","volume":"38","author":"C Moschella","year":"2001","unstructured":"Moschella C, Jaber BL. Interaction between cyclosporine and Hypericum perforatum (St. John\u2019s wort) after organ transplantation. Am J Kidney Dis. 2001;38:1105\u20137.","journal-title":"Am J Kidney Dis"},{"key":"9146_CR61","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1432-2277.2003.tb00345.x","volume":"16","author":"DM Alscher","year":"2003","unstructured":"Alscher DM, Klotz U. Drug interaction of herbal tea containing St. John\u2019s wort with cyclosporine. Transpl Int. 2003;16:543\u20134.","journal-title":"Transpl Int"},{"key":"9146_CR62","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1097\/00007890-200203270-00035","volume":"73","author":"R Bolley","year":"2002","unstructured":"Bolley R, Z\u00fclke C, Kammerl M, Fischereder M, Kr\u00e4mer BK. Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with St John\u2019s wort. Transplantation. 2002;73:1009.","journal-title":"Transplantation"},{"key":"9146_CR63","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1177\/0091270003261078","volume":"44","author":"MF Hebert","year":"2004","unstructured":"Hebert MF, Park JM, Chen YL, Akhtar S, Larson AM. Effects of St. John\u2019s wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers. J Clin Pharmacol. 2004;44:89\u201394.","journal-title":"J Clin Pharmacol"},{"key":"9146_CR64","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/ndt\/gfg002","volume":"18","author":"I Mai","year":"2003","unstructured":"Mai I, St\u00f6rmer E, Bauer S, Kr\u00fcger H, Budde K, Roots I. Impact of St John\u2019s wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients. Nephrol Dial Transplant. 2003;18:819\u201322.","journal-title":"Nephrol Dial Transplant"},{"key":"9146_CR65","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1024\/0369-8394.94.23.987","volume":"94","author":"M Saraga","year":"2005","unstructured":"Saraga M, Zullino DF. St. John\u2019s wort, corticosteroids, cocaine, alcohol and a first manic episode. Praxis (Bern 1994). 2005;94:987\u20139.","journal-title":"Praxis (Bern 1994)"},{"key":"9146_CR66","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1345\/aph.1K316","volume":"41","author":"EC Bell","year":"2007","unstructured":"Bell EC, Ravis WR, Chan HM, Lin YJ. Lack of pharmacokinetic interaction between St. John\u2019s wort and prednisone. Ann Pharmacother. 2007;41:1819\u201324.","journal-title":"Ann Pharmacother"},{"key":"9146_CR67","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/S0140-6736(05)73227-X","volume":"355","author":"QY Yue","year":"2000","unstructured":"Yue QY, Bergquist C, Gerd\u00e9n B. Safety of St John\u2019s wort (Hypericum perforatum). Lancet. 2000;355:576\u20137.","journal-title":"Lancet"},{"key":"9146_CR68","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1046\/j.1365-2125.2003.02005.x","volume":"56","author":"A Pfrunder","year":"2003","unstructured":"Pfrunder A, Schiesser M, Gerber S, Haschke M, Bitzer J, Drewe J. Interaction of St John\u2019s wort with low-dose oral contraceptive therapy: a randomized controlled trial. Br J Clin Pharmacol. 2003;56:683\u201390.","journal-title":"Br J Clin Pharmacol"},{"key":"9146_CR69","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.contraception.2004.11.004","volume":"71","author":"PA Murphy","year":"2005","unstructured":"Murphy PA, Kern SE, Stanczyk FZ, Westhoff CL. Interaction of St. John\u2019s wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding. Contraception. 2005;71:402\u20138.","journal-title":"Contraception"},{"key":"9146_CR70","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1046\/j.1365-2125.2003.01716.x","volume":"55","author":"UI Schwarz","year":"2003","unstructured":"Schwarz UI, B\u00fcschel B, Kirch W. Unwanted pregnancy on self-medication with St John\u2019s wort despite hormonal contraception. Br J Clin Pharmacol. 2003;55:112\u20133.","journal-title":"Br J Clin Pharmacol"},{"key":"9146_CR71","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1001\/jama.236.12.1382","volume":"236","author":"JL Skolnick","year":"1976","unstructured":"Skolnick JL, Stoler BS, Katz DB, Anderson WH. Rifampin, oral contraceptives, and pregnancy. JAMA. 1976;236:1382.","journal-title":"JAMA"},{"key":"9146_CR72","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1517\/14656566.9.6.1039","volume":"9","author":"G Lazovic","year":"2008","unstructured":"Lazovic G, Radivojevic U, Marinkovic J. Tibolone: the way to beat many a postmenopausal ailments. Expert Opin Pharmacother. 2008;9:1039\u201347.","journal-title":"Expert Opin Pharmacother"},{"key":"9146_CR73","first-page":"36","volume":"71","author":"F Etogo-Asse","year":"2008","unstructured":"Etogo-Asse F, Boemer F, Sempoux C, Geubel A. Acute hepatitis with prolonged cholestasis and disappearance of interlobular bile ducts following tibolone and Hypericum perforatum (St. John\u2019s wort). Case of drug interaction? Acta Gastroenterol Belg. 2008;71:36\u20138.","journal-title":"Acta Gastroenterol Belg"},{"key":"9146_CR74","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1177\/00912709922011764","volume":"39","author":"SM Huang","year":"1999","unstructured":"Huang SM, Lesko LJ, Williams RL. Assessment of the quality and quantity of drug-drug interaction studies in recent NDA submissions: study design and data analysis issues. J Clin Pharmacol. 1999;39:1006\u201314.","journal-title":"J Clin Pharmacol"},{"key":"9146_CR75","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/cpt1974162348","volume":"16","author":"RA O\u2019Reilly","year":"1974","unstructured":"O\u2019Reilly RA. Studies on the optical enantiomorphs of warfarin in man. Clin Pharmacol Ther. 1974;16:348\u201354.","journal-title":"Clin Pharmacol Ther"},{"key":"9146_CR76","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/j.1365-2125.2003.02051.x","volume":"57","author":"X Jiang","year":"2004","unstructured":"Jiang X, Williams KM, Liauw WS, Ammit AJ, Roufogalis BD, Duke CC, et al. Effect of St John\u2019s wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol. 2004;57:592\u20139.","journal-title":"Br J Clin Pharmacol"},{"key":"9146_CR77","first-page":"A22","volume":"55","author":"F Donath","year":"1999","unstructured":"Donath F, Roots I, Langheinrich M, et al. Interaction of St John\u2019s wort extract with phenprocoumon. Eur J Clin Pharmacol. 1999;55:A22.","journal-title":"Eur J Clin Pharmacol"},{"key":"9146_CR78","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1067\/mcp.2001.120025","volume":"70","author":"K Sugimoto","year":"2001","unstructured":"Sugimoto K, Ohmori M, Tsuruoka S, Nishiki K, Kawaguchi A, Harada K, et al. Different effects of St John\u2019s wort on the pharmacokinetics of simvastatin and pravastatin. Clin Pharmacol Ther. 2001;70:518\u201324.","journal-title":"Clin Pharmacol Ther"},{"key":"9146_CR79","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00228-007-0345-x","volume":"63","author":"L Andr\u00e9n","year":"2007","unstructured":"Andr\u00e9n L, Andreasson A, Eggertsen R. Interaction between a commercially available St. John\u2019s wort product (Movina) and atorvastatin in patients with hypercholesterolemia. Eur J Clin Pharmacol. 2007;63:913\u20136.","journal-title":"Eur J Clin Pharmacol"},{"key":"9146_CR80","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1365-2125.2008.03344.x","volume":"67","author":"XD Wang","year":"2009","unstructured":"Wang XD, Li JL, Su QB, Guan S, Chen J, Du J, et al. Impact of the haplotypes of the human pregnane X receptor gene on the basal and St John\u2019s wort-induced activity of cytochrome P450 3A4 enzyme. Br J Clin Pharmacol. 2009;67:255\u201361.","journal-title":"Br J Clin Pharmacol"},{"key":"9146_CR81","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.clpt.2003.12.012","volume":"75","author":"C Tannergren","year":"2004","unstructured":"Tannergren C, Engman H, Knutson L, Hedeland M, Bondesson U, Lennern\u00e4s H. St John\u2019s wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism. Clin Pharmacol Ther. 2004;75:298\u2013309.","journal-title":"Clin Pharmacol Ther"},{"key":"9146_CR82","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1358\/dot.2008.44.3.1193864","volume":"44","author":"JC Tardif","year":"2008","unstructured":"Tardif JC. Ivabradine: I(f) inhibition in the management of stable angina pectoris and other cardiovascular diseases. Drugs Today (Barc). 2008;44:171\u201381.","journal-title":"Drugs Today (Barc)"},{"key":"9146_CR83","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1177\/0091270006291623","volume":"46","author":"A Portol\u00e9s","year":"2006","unstructured":"Portol\u00e9s A, Terleira A, Calvo A, Mart\u00ednez I, Resplandy G. Effects of Hypericum perforatum on ivabradine pharmacokinetics in healthy volunteers: an open-label, pharmacokinetic interaction clinical trial. J Clin Pharmacol. 2006;46:1188\u201394.","journal-title":"J Clin Pharmacol"},{"key":"9146_CR84","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1080\/03602530600754065","volume":"38","author":"CJ van den Bout-van den Beukel","year":"2006","unstructured":"van den Bout-van den Beukel CJ, Koopmans PP, van der Ven AJ, De Smet PA, Burger DM. Possible drug\u2013metabolism interactions of medicinal herbs with antiretroviral agents. Drug Metab Rev. 2006;38:477\u2013514.","journal-title":"Drug Metab Rev"},{"key":"9146_CR85","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0140-6736(99)05712-8","volume":"355","author":"SC Piscitelli","year":"2000","unstructured":"Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, Falloon J. Indinavir concentrations and St John\u2019s wort. Lancet. 2000;355:547\u20138.","journal-title":"Lancet"},{"key":"9146_CR86","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.2165\/00003495-200565090-00005","volume":"65","author":"Z Hu","year":"2005","unstructured":"Hu Z, Yang X, Ho PC, Chan SY, Heng PW, Chan E, et al. Herb\u2013drug interactions: a literature review. Drugs. 2005;65:1239\u201382.","journal-title":"Drugs"},{"key":"9146_CR87","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/00002030-200102160-00019","volume":"15","author":"MM Maat de","year":"2001","unstructured":"de Maat MM, Hoetelmans RM, Math t RA, van Gorp EC, Meenhorst PL, Mulder JW, et al. Drug interaction between St John\u2019s wort and nevirapine. AIDS. 2001;15:420\u20131.","journal-title":"AIDS"},{"key":"9146_CR88","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/S0090-9556(24)14960-4","volume":"27","author":"DA Erickson","year":"1999","unstructured":"Erickson DA, Mather G, Trager WF, Levy RH, Keirns JJ. Characterization of the in vitro biotransformation of the HIV-1 reverse transcriptase inhibitor nevirapine by human hepatic cytochromes P-450. Drug Metab Dispos. 1999;27:1488\u201395.","journal-title":"Drug Metab Dispos"},{"key":"9146_CR89","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1634\/theoncologist.11-7-742","volume":"11","author":"I Meijerman","year":"2006","unstructured":"Meijerman I, Beijnen JH, Schellens JH. Herb\u2013drug interactions in oncology: focus on mechanisms of induction. Oncologist. 2006;11:742\u201352.","journal-title":"Oncologist"},{"key":"9146_CR90","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/jnci\/94.16.1247","volume":"94","author":"RH Mathijssen","year":"2002","unstructured":"Mathijssen RH, Verweij J, de Bruijn P, Loos WJ, Sparreboom A. Effects of St. John\u2019s wort on irinotecan metabolism. J Natl Cancer Inst. 2002;94:1247\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"9146_CR91","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.clpt.2004.06.007","volume":"76","author":"RF Frye","year":"2004","unstructured":"Frye RF, Fitzgerald SM, Lagattuta TF, Hruska MW, Egorin MJ. Effect of St John\u2019s wort on imatinib mesylate pharmacokinetics. Clin Pharmacol Ther. 2004;76:323\u20139.","journal-title":"Clin Pharmacol Ther"},{"key":"9146_CR92","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1592\/phco.24.16.1508.50958","volume":"24","author":"P Smith","year":"2004","unstructured":"Smith P, Bullock JM, Booker BM, Haas CE, Berenson CS, Jusko WJ. The influence of St. John\u2019s wort on the pharmacokinetics and protein binding of imatinib mesylate. Pharmacotherapy. 2004;24:1508\u201314.","journal-title":"Pharmacotherapy"},{"key":"9146_CR93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.1875-9114.1990.tb02545.x","volume":"10","author":"A Kales","year":"1990","unstructured":"Kales A. Quazepam: hypnotic efficacy and side effects. Pharmacotherapy. 1990;10:1\u201310.","journal-title":"Pharmacotherapy"},{"key":"9146_CR94","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1365-2125.2004.02171.x","volume":"58","author":"A Kawaguchi","year":"2004","unstructured":"Kawaguchi A, Ohmori M, Tsuruoka S, Nishiki K, Harada K, Miyamori I, et al. Drug interaction between St John\u2019s wort and quazepam. Br J Clin Pharmacol. 2004;58:403\u201310.","journal-title":"Br J Clin Pharmacol"},{"key":"9146_CR95","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1177\/026988110201600420","volume":"16","author":"M Dannawi","year":"2002","unstructured":"Dannawi M. Possible serotonin syndrome after combination of buspirone and St John\u2019s wort. J Psychopharmacol. 2002;16:401.","journal-title":"J Psychopharmacol"},{"key":"9146_CR96","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/02699050110103319","volume":"16","author":"M Spinella","year":"2002","unstructured":"Spinella M, Eaton LA. Hypomania induced by herbal and pharmaceutical psychotropic medicines following mild traumatic brain injury. Brain Inj. 2002;16:359\u201367.","journal-title":"Brain Inj"},{"key":"9146_CR97","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/089198879901200103","volume":"12","author":"MS Lantz","year":"1999","unstructured":"Lantz MS, Buchalter E, Giambanco V. St. John\u2019s wort and antidepressant drug interactions in the elderly. J Geriatr Psychiatry Neurol. 1999;12:7\u201310.","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"9146_CR98","first-page":"950","volume":"57","author":"JB Gordon","year":"1998","unstructured":"Gordon JB. SSRIs and St John\u2019s wort: possible toxicity? Am Fam Phys. 1998;57:950.","journal-title":"Am Fam Phys"},{"key":"9146_CR99","first-page":"1285","volume":"29","author":"N Prost","year":"2000","unstructured":"Prost N, Tichadou L, Rodor F, Nguyen N, David JM, Jean-Pastor MJ. St. Johns wort\u2013venlafaxine interaction. Presse Med. 2000;29:1285\u20136.","journal-title":"Presse Med"},{"key":"9146_CR100","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1177\/026988110001400113","volume":"14","author":"DM Barbenel","year":"2000","unstructured":"Barbenel DM, Yusufi B, O\u2019Shea D, Bench CJ. Mania in a patient receiving testosterone replacement postorchidectomy taking St John\u2019s wort and sertraline. J Psychopharmacol. 2000;14:84\u20136.","journal-title":"J Psychopharmacol"},{"key":"9146_CR101","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1046\/j.0306-5251.2001.01469.x","volume":"52","author":"A Fugh-Berman","year":"2001","unstructured":"Fugh-Berman A, Ernst E. Herb\u2013drug interactions: review and assessment of report reliability. Br J Clin Pharmacol. 2001;52:587\u201395.","journal-title":"Br J Clin Pharmacol"},{"key":"9146_CR102","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/00004714-200202000-00008","volume":"22","author":"A Johne","year":"2002","unstructured":"Johne A, Schmider J, Brockm\u00f6ller J, Stadelmann AM, St\u00f6rmer E, Bauer S, et al. Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John\u2019s wort (Hypericum perforatum). J Clin Psychopharmacol. 2002;22:46\u201354.","journal-title":"J Clin Psychopharmacol"},{"key":"9146_CR103","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1067\/mcp.2000.111530","volume":"68","author":"AH Burstein","year":"2000","unstructured":"Burstein AH, Horton RL, Dunn T, Alfaro RM, Piscitelli SC, Theodore W. Lack of effect of St John\u2019s wort on carbamazepine pharmacokinetics in healthy volunteers. Clin Pharmacol Ther. 2000;68:605\u201312.","journal-title":"Clin Pharmacol Ther"},{"key":"9146_CR104","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1016\/0006-2952(94)90071-X","volume":"47","author":"BM Kerr","year":"1994","unstructured":"Kerr BM, Thummel KE, Wurden CJ, Klein SM, Kroetz DL, Gonzalez FJ, et al. Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation. Biochem Pharmacol. 1994;47:1969\u201379.","journal-title":"Biochem Pharmacol"},{"key":"9146_CR105","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00228-004-0823-3","volume":"60","author":"A Johne","year":"2004","unstructured":"Johne A, Perloff ES, Bauer S, Schmider J, Mai I, Brockm\u00f6ller J, et al. Impact of cytochrome P-450 inhibition by cimetidine and induction by carbamazepine on the kinetics of hypericin and pseudohypericin in healthy volunteers. Eur J Clin Pharmacol. 2004;60:617\u201322.","journal-title":"Eur J Clin Pharmacol"},{"key":"9146_CR106","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1001\/jama.286.2.208","volume":"286","author":"MK Ang-Lee","year":"2001","unstructured":"Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA. 2001;286:208\u201316.","journal-title":"JAMA"},{"key":"9146_CR107","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1097\/00000542-200204000-00035","volume":"96","author":"S Crowe","year":"2002","unstructured":"Crowe S, McKeating K. Delayed emergence and St. John\u2019s wort. Anesthesiology. 2002;96:1025\u20137.","journal-title":"Anesthesiology"},{"key":"9146_CR108","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S0952-8180(00)00199-9","volume":"12","author":"S Irefin","year":"2000","unstructured":"Irefin S, Sprung J. A possible cause of cardiovascular collapse during anesthesia: long-term use of St. John\u2019s wort. J Clin Anesth. 2000;12:498\u20139.","journal-title":"J Clin Anesth"},{"key":"9146_CR109","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1055\/s-2003-38090","volume":"36","author":"D Eich-H\u00f6chli","year":"2003","unstructured":"Eich-H\u00f6chli D, Oppliger R, Golay KP, Baumann P, Eap CB. Methadone maintenance treatment and St. John\u2019s wort\u2014a case report. Pharmacopsychiatry. 2003;36:35\u20137.","journal-title":"Pharmacopsychiatry"},{"key":"9146_CR110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/COPD.S1121","volume":"3","author":"S Wilkes","year":"2008","unstructured":"Wilkes S. The use of bupropion SR in cigarette smoking cessation. Int J Chron Obstruct Pulmon Dis. 2008;3:45\u201353.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"9146_CR111","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/j.1365-2125.2007.02962.x","volume":"64","author":"JC Milton","year":"2007","unstructured":"Milton JC, Abdulla A. Prolonged oro-facial dystonia in a 58\u00a0year old female following therapy with bupropion and St John\u2019s wort. Br J Clin Pharmacol. 2007;64:717\u20138.","journal-title":"Br J Clin Pharmacol"},{"key":"9146_CR112","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.ajem.2004.09.013","volume":"22","author":"SM Bryant","year":"2004","unstructured":"Bryant SM, Kolodchak J. Serotonin syndrome resulting from an herbal detox cocktail. Am J Emerg Med. 2004;22:625\u20136.","journal-title":"Am J Emerg Med"},{"key":"9146_CR113","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1358\/dot.2004.40.1.799438","volume":"40","author":"TT Hansel","year":"2004","unstructured":"Hansel TT, Tennant RC, Tan AJ, Higgins LA, Neighbour H, Erin EM, et al. Theophylline: mechanism of action and use in asthma and chronic obstructive pulmonary disease. Drugs Today (Barc). 2004;40:55\u201369.","journal-title":"Drugs Today (Barc)"},{"key":"9146_CR114","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1345\/aph.18252","volume":"33","author":"A Nebel","year":"1999","unstructured":"Nebel A, Schneider BJ, Baker RK, Kroll DJ. Potential metabolic interaction between St. John\u2019s wort and theophylline. Ann Pharmacother. 1999;33:502.","journal-title":"Ann Pharmacother"},{"key":"9146_CR115","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/0091270003261496","volume":"44","author":"T Morimoto","year":"2004","unstructured":"Morimoto T, Kotegawa T, Tsutsumi K, Ohtani Y, Imai H, Nakano S. Effect of St. John\u2019s wort on the pharmacokinetics of theophylline in healthy volunteers. J Clin Pharmacol. 2004;44:95\u2013101.","journal-title":"J Clin Pharmacol"},{"key":"9146_CR116","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1038\/sj.bjp.0707685","volume":"153","author":"H Xu","year":"2008","unstructured":"Xu H, Williams KM, Liauw WS, Murray M, Day RO, McLachlan AJ. Effects of St John\u2019s wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide. Br J Pharmacol. 2008;153:1579\u201386.","journal-title":"Br J Pharmacol"},{"key":"9146_CR117","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/FTD.0b013e3181898b0c","volume":"30","author":"RJ Br\u00fcggemann","year":"2008","unstructured":"Br\u00fcggemann RJ, Donnelly JP, Aarnoutse RE, Warris A, Blijlevens NM, Mouton JW, et al. Therapeutic drug monitoring of voriconazole. Ther Drug Monit. 2008;30:403\u201311.","journal-title":"Ther Drug Monit"},{"key":"9146_CR118","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1586\/14737175.6.10.1413","volume":"6","author":"G Sandrini","year":"2006","unstructured":"Sandrini G, Perrotta A, Nappi G. Eletriptan: a review and new perspectives. Expert Rev Neurother. 2006;6:1413\u201321.","journal-title":"Expert Rev Neurother"},{"key":"9146_CR119","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/j.1468-2982.2007.01430.x","volume":"27","author":"N Bonetto","year":"2007","unstructured":"Bonetto N, Santelli L, Battistin L, Cagnin A. Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and hypericum. Cephalalgia. 2007;27:1421\u20133.","journal-title":"Cephalalgia"},{"key":"9146_CR120","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00228-008-0538-y","volume":"64","author":"S Shi","year":"2008","unstructured":"Shi S, Klotz U. Proton pump inhibitors: an update of their clinical use and pharmacokinetics. Eur J Clin Pharmacol. 2008;64:935\u201351.","journal-title":"Eur J Clin Pharmacol"},{"key":"9146_CR121","first-page":"S11","volume":"7","author":"DE Baker","year":"2007","unstructured":"Baker DE. Loperamide: a pharmacological review. Rev Gastroenterol Disord. 2007;7:S11\u20138.","journal-title":"Rev Gastroenterol Disord"},{"key":"9146_CR122","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1176\/ps.50.7.969a","volume":"50","author":"IS Khawaja","year":"1999","unstructured":"Khawaja IS, Marotta RF, Lippmann S. Herbal medicines as a factor in delirium. Psychiatr Serv. 1999;50:969\u201370.","journal-title":"Psychiatr Serv"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-009-9146-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12248-009-9146-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-009-9146-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-009-9146-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T17:48:01Z","timestamp":1739382481000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12248-009-9146-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,27]]},"references-count":122,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["9146"],"URL":"https:\/\/doi.org\/10.1208\/s12248-009-9146-8","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,27]]},"article-number":"710"}}